Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GLUT1 inhibitors(Glucose transporter 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H17N5O2S |
InChIKeyUGZNEGXKULPTKF-UHFFFAOYSA-N |
CAS Registry2772785-94-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | US | 17 Aug 2018 |